GWAS HUMANOMNI5 + EXOME + CUSTOM 300,000 BEADTYPES FOR NCI (HAIMAN)

NCI (HAIMAN) 的 GWAS HUMANOMNI5 外显子组定制 300,000 种珠型

基本信息

批准号：
8759375
负责人：
SONIA DUA
金额：
$ 414万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/8759375
关键词：
Animal Model Arthritis Child Child health care Contracts Custom Diabetes Mellitus Digestive System Disorders Disease Extramural Activities Funding Genetic Medicine Genetic Services Genotype Government Grant Human Development Inherited Institutes Kidney Diseases Musculoskeletal Diseases NIH Program Announcements National Cancer Institute National Eye Institute National Human Genome Research Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Dental and Craniofacial Research National Institute of Drug Abuse National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Deafness and Other Communication Disorders Peer Review Principal Investigator Process Qualifying Research Scientist Services Support Contracts United States National Institutes of Health Universities exome genome wide association study human disease programs skin disorder

项目摘要

The Center for Inherited Disease Research (CIDR) is a centralized facility that provides genotyping, sequencing and statistical genetics services for qualifying National Institutes of Health (NIH)-funded projects. These services are available to extramural and intramural scientists supported by the institutes participating in the CIDR program. CIDR's main focus is high-throughput projects relating to human disease. However, some smaller projects and projects involving model organisms can also be accommodated. Currently, 14 NIH institutes participate: The National Cancer Institute (NCI); the National Eye Institute (NEI); the National Human Genome Research Institute (NHGRI); the National Institute on Aging (NIA); the National Institute on Alcohol Abuse and Alcoholism (NIAAA); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); the National Institute of Child Health and Human Development (NICHD); the National Institute on Drug Abuse (NIDA); the National Institute on Deafness and Other Communication Disorders (NIDCD); the National Institute of Dental and Craniofacial Research (NIDCR); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the National Institute of Environmental Health Sciences (NIEHS); the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS). Access to CIDR is granted via a peer review process (NIH program announcement: PAR 11-210). The facility is supported through a five-year, $115 million federal contract (number N01-HG-72096) to The Johns Hopkins University (JHU) with Dr. David Valle of the JHU Institute of Genetic Medicine as Principal Investigator. Dr. Lawrence C. Brody of the National Human Genome Research Institute (NHGRI) serves as CIDR's Chief Scientific Officer. Ms. Gloria Dunnigan, NHGRI, serves as the government Project Officer. Dr. Camilla Day, NHGRI, serves as Scientific Review Officer and Executive Director of the CIDR Board of Governors.

继承疾病研究中心（CIDR）是一个集中式设施，为合格的国家卫生研究院（NIH）资助的项目提供基因分型，测序和统计遗传学服务。这些服务适用于参加CIDR计划的机构支持的壁外和壁内科学家。 CIDR的主要重点是与人类疾病有关的高通量项目。但是，也可以容纳一些涉及模型生物的较小的项目和项目。目前，14个NIH机构参加：国家癌症研究所（NCI）；国家眼科研究所（NEI）；国家人类基因组研究所（NHGRI）；国家老化研究所（NIA）；美国国家酒精滥用与酒精中毒研究所（NIAAA）；美国国家关节炎，肌肉骨骼和皮肤病研究所（NIAMS）；国家儿童健康与人类发展研究所（NICHD）；美国国家药物滥用研究所（NIDA）；美国聋和其他沟通障碍研究所（NIDCD）；国家牙科与颅面研究所（NIDCR）；美国国家糖尿病与消化和肾脏疾病研究所（NIDDK）；美国国家环境健康科学研究所（NIEHS）；美国国家心理健康研究所（NIMH）和国家神经系统疾病与中风研究所（NINDS）。通过同行评审过程（NIH计划公告：11-210）授予CIDR的访问权限。该设施通过与JHU遗传医学研究所的David Valle博士担任首席研究员的约翰·霍普金斯大学（JHU）的五年，1.15亿美元的联邦合同（N01-HG-72096号）。国家人类基因组研究所（NHGRI）的Lawrence C. Brody博士担任CIDR首席科学官。 NHGRI的Gloria Dunnigan女士担任政府项目官员。 NHGRI的Camilla Day博士担任CIDR理事会的科学审查官和执行董事。